NegotiumBio LLC & GmbH

Basel, Switzerland (GmbH) / Greater Boston, MA (LLC)
Small Molecules Biologics Cell Therapy Gene Therapy CAR-T Viral Vectors Oligonucleotides
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: NegotiumBio LLC & GmbH

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Basel, Switzerland (GmbH) / Greater Boston, MA (LLC)
Modalities
Small Molecules, Biologics, Cell Therapy, Gene Therapy, CAR-T, Viral Vectors, Oligonucleotides
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSmall Molecules, Biologics, Cell Therapy, Gene Therapy, CAR-T, Viral Vectors, Oligonucleotides
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (7 modalities)
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Small Molecules CDMOs → Biologics CDMOs → Cell Therapy CDMOs → Gene Therapy CDMOs → CAR-T CDMOs → Viral Vectors CDMOs → Oligonucleotides CDMOs →

Similar CDMOs

Novartis
Basel, Switzerland
Signal Score: 90.7
CAR-T, Gene Therapy
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 80.2
CAR-T, Cell Therapy, iPSC, Gene Editing
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Signal Score: 73.3
mRNA, Gene Therapy, Cell Therapy
GenScript
Piscataway, NJ / Nanjing, China
Signal Score: 65.5
CAR-T, Cell Therapy, Gene Editing
Minaris (WuXi Advanced Therapies)
Philadelphia, PA / Yokohama, Japan
Signal Score: 60.5
CAR-T, Cell Therapy